United Kingdom · 
Who invested in Metacarpal?
Metacarpal's investors include Scottish Enterprise.
2025
$1.0MRound$1.1MSeed$555KRound
United Kingdom · Seed startup
Who invested in Metacarpal
Funding summaryUpdated 26 Oct 2026
$2.7Mraised across 3 rounds since 2024, from 3 sources
$1.0MRound$1.1MSeed$555KRound
- Latest round
- Round, $555KNov 2025
- Biggest round
- $1.1MSeed · Aug 2024
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $1.0M Apr 2024
- Biggest round
- $1.1M Seed · Aug 2024
- Usual gap between rounds
- 16 months the median of 2
The rounds
- Nov 2025Round$555K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Aug 2024
- Apr 2024Round$1.0M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Funding filed with regulators
Metacarpal filed 3 raises, $1.6M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Nov 2025$555KUK share allotment
- Apr 2024$855KUK share allotment
- Apr 2024$151KUK share allotment
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Metacarpal
How much has Metacarpal raised?
Metacarpal has raised $2.7M across 3 rounds since 2024.
When did Metacarpal last raise?
Metacarpal's most recent round, $555K, was in Nov 2025.
What was Metacarpal's biggest round?
Metacarpal's largest round on record is $1.1M (Seed), in Aug 2024.
Who backed Metacarpal first?
Metacarpal's first round on record, in Aug 2024, was backed by Scottish Enterprise.
What stage is Metacarpal at?
Metacarpal's latest named round is a Seed, in Aug 2024.
Where is Metacarpal based?
Metacarpal is based in the United Kingdom.
Companies like Metacarpal
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.